Rafael Santana-Davila
@valdesan.bsky.social
2.6K followers
2K following
250 posts
Thoracic, Head and Neck oncologist #medsky #oncsky
Fred Hutch Cancer Center. @fredhutch.bsky.social
University of Washington.
Posts
Media
Videos
Starter Packs
Pinned
Reposted by Rafael Santana-Davila
Reposted by Rafael Santana-Davila
Reposted by Rafael Santana-Davila
Reposted by Rafael Santana-Davila
Aaron Rupar
@atrupar.com
· 20d
Reposted by Rafael Santana-Davila
Reposted by Rafael Santana-Davila
Reposted by Rafael Santana-Davila
Jarushka Naidoo
@drjnaidoo.bsky.social
· Jun 19
Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN study
We report a pilot clinical trial investigating the feasibility of liquid biopsy genotyping
(LBG) at the time of radiological suspicion of advanced NSCLC, incorporating a micro-cost
model (MCM). (PLAsm...
www.ejcancer.com
Reposted by Rafael Santana-Davila
Reposted by Rafael Santana-Davila
Reposted by Rafael Santana-Davila
Reposted by Rafael Santana-Davila
Reposted by Rafael Santana-Davila
Gregory Riely
@rielymd.bsky.social
· Jun 1
Zipalertinib in Patients With <i>EGFR</i> Exon 20 Insertion-Positive NSCLC Previously Treated With Platinum-Based Chemotherapy With or Without Amivantamab
PURPOSETo evaluate the safety and efficacy of zipalertinib, an irreversible epidermal growth
factor receptor (EGFR) inhibitor, in pretreated patients with non-small cell lung
cancer (NSCLC) harboring ...
ascopubs.org
Reposted by Rafael Santana-Davila
Reposted by Rafael Santana-Davila
Reposted by Rafael Santana-Davila